Literature DB >> 4554185

Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man.

P L Weiden, R M Blaese, W Strober, J B Block, T A Waldmann.   

Abstract

Intestinal lymphangiectasia is a disease characterized by hypoproteinemia and edema resulting from protein-losing gastroenteropathy secondary to abnormal intestinal lymphatics. Immunologic abnormalities associated with this disease include hypogammaglobulinemia, lymphocytopenia, skin anergy, and impaired allograft rejection. In the present study, the in vitro blastogenic transformation of lymphocytes from 12 patients with intestinal lymphangiectasia was assessed in order to gain insight into the mechanism of the cellular immune defect in this disease. Peripheral blood lymphocytes from patients with intestinal lymphagiectasia showed impaired in vitro transformation to nonspecific mitogens, specific antigens, and allogeneic cells when compared to equal numbers of cells from normal individuals. Patients with the most deficient in vitro reactivity tended to have the lowest serum albumin concentration and the lowest absolute lymphocyte count. Lymphocytes obtained from chylous effusions in each of the four patients studied transformed more vigorously than peripheral blood cells from the same patients. These results may be explained by the loss of recirculating, long-lived lymphocytes into the gastrointestinal tract, resulting in a relative depletion of the population of lymphocytes necessary for in vitro blast transformation. This disease thus represents a clinical analogue of animals with experimental thoracic duct drainage, and provides evidence for the existence, in man, of two functionally distinct lymphocyte populations. In addition, these findings establish a new mechanism of impaired delayed hypersensitivity and defective in vitro lymphocyte transformation, i.e. the gastrointestinal loss and consequent depletion of the long-lived, recirculating population of lymphocytes from the peripheral lymphocyte pool.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4554185      PMCID: PMC292269          DOI: 10.1172/JCI106928

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Albumin metabolism in patients with Whipple's disease.

Authors:  L Laster; T A Waldmann; L F Fenster; J W Singleton
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

Review 2.  The role of the gastrointestinal tract in plasma protein metabolism. Studies with 51Cr-albumin.

Authors:  T A Waldmann; R D Wochner; W Strober
Journal:  Am J Med       Date:  1969-02       Impact factor: 4.965

Review 3.  The traffic of lymphocytes.

Authors:  W L Ford; J L Gowans
Journal:  Semin Hematol       Date:  1969-01       Impact factor: 3.851

4.  Tricuspid regurgitation. A newly recognized cause of protein-losing enteropathy, lymphocytopenia and immunologic deficiency.

Authors:  W Strober; L S Cohen; T A Waldmann; E Braunwald
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

Review 5.  Lymphopoiesis in the thymus and other tissues: functional implications.

Authors:  N B Everett; R W Tyler
Journal:  Int Rev Cytol       Date:  1967

Review 6.  Protein-losing enteropathy.

Authors:  T A Waldmann
Journal:  Gastroenterology       Date:  1966-03       Impact factor: 22.682

7.  Phytohemagglutinin response of recirculating and non-recirculating rat lymphocytes.

Authors:  J G Iversen
Journal:  Exp Cell Res       Date:  1969-08       Impact factor: 3.905

8.  Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome.

Authors:  J J Oppenheim; R M Blaese; T A Waldmann
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

9.  Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes.

Authors:  J J Oppenheim; R A Wolstencroft; P G Gell
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

10.  Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection.

Authors:  W Strober; R D Wochner; P P Carbone; T A Waldmann
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

View more
  16 in total

1.  Comparative, immunological studies on lymphangiectasia of the small intestine revealed in protein losing gastroenteropathy and Behçet's disease.

Authors:  M Tsuchiya; T Hibi; Y Mizuno; A Ono; A Morita
Journal:  Gastroenterol Jpn       Date:  1976

2.  Intestinal lymphangiectasia in adults.

Authors:  Hugh James Freeman; Michael Nimmo
Journal:  World J Gastrointest Oncol       Date:  2011-02-15

3.  Lymphocyte subpopulations in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

4.  Impaired neutrophil function in intestinal lymphangiectasia.

Authors:  R P Bolton; K L Cotter; M S Losowsky
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

5.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

6.  Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).

Authors:  G Sherwood; R M Blaese
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

7.  Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.

Authors:  E W Gelfand; H M Dosch; W D Biggar; I H Fox
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

8.  Development of impaired splenic function in intestinal lymphangiectasia.

Authors:  P N Foster; A W Bullen; D A Robertson; D M Chalmers; M S Losowsky
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

9.  Intestinal lymphangiectasia and thymic hypoplasia.

Authors:  R U Sorensen; T C Halpin; C R Abramowsky; D L Hornick; K M Miller; P Naylor; G S Incefy
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

10.  Intestinal lymphangiectasia. Long-term results with MCT diet.

Authors:  W L Tift; J K Lloyd
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.